Computer system and computer implemented method for real-time drug interaction checker

• US 10,026,137 B1
• Filed: 11/17/2011
• Issued: 07/17/2018
• Est. Priority Date: 11/17/2010
• Status: Active Grant

• Current Assignee: Express Scripts Strategic Development, Inc. (The Cigna Group)
• Original Assignee: Express Scripts Strategic Development, Inc. (The Cigna Group)
• Inventors: Rosen, Donna, Anand, Tejwansh, Esterlis, Yakov, Bidell, Eileen, Bradbury, Keith, Heller, Judith
• Primary Examiner(s): Lubin, Valerie
• Application Number:
  US13/299,330
• Time in Patent Office: 2,434 Days
• Field of Search: 705 2, 705 3, 705 14, 700237
• CPC Class Codes: G06Q 30/00 Commerce
• CPC Class Codes: G06Q 50/22 Social work or social welfare, e.g. community support activities or counselling services
• CPC Class Codes: G16H 20/10 relating to drugs or medications, e.g. for ensuring correct administration to patients
• CPC Class Codes: G16H 70/40 relating to drugs, e.g. their side effects or intended usage

Abstract

A computer system and computer implemented method for performing web-based drug interaction screening utilizing access a patient'"'"'s prescription history stored in the pharmacy'"'"'s prescription history or in the health plan'"'"'s claim history.

Claims

1. A method comprising:

receiving, via the Internet on a computing device, a purchase selection from a user device of an over-the-counter (OTC) drug product;

receiving, via the Internet on the computing device, associated usage data reflecting a purchaser indication via the user device of whether the OTC drug product is for chronic use or acute use;

accessing, on the computing device, a claims database storing claims data of a patient associated with the OTC drug product;

accessing, on the computing device, a second computing device;

receiving, on the computing device, a token from the second computing device, the token being valid for a predetermined period of time;

in response to receipt of the purchaser indication that the OTC drug product is for chronic use, transmitting, on the computing device, a request and the token to the second computing device to perform a drug utilization review (DUR) based on the OTC drug product and the claims data of the patient;

receiving, on the computing device, a drug interaction alert based on performance of the DUR when the token is valid;

when the drug interaction alert is for a severe interaction, generating and transmitting a notification to the user device via the Internet reflecting that purchase of the OTC drug product cannot be completed based on the drug interaction alert; and

when the drug interaction alert is not for a severe interaction, processing the purchase selection of the identified OTC drug product,

wherein the computing device prompts a user to re-login when the token is not valid.

2. The method of claim 1, further comprising:

classifying the drug interaction alert as being for a severe interaction or for a non-severe interaction.

3. The method of claim 1, further comprising:

altering a drug profile of the patient to reflect acute use of the OTC drug product.

4. The method of claim 1, further comprising:

identifying a purchaser of the OTC product as the patient,

wherein access of the claims data and performance of the DUR is based on identification of the purchaser.

5. The method of claim 1, wherein the drug interaction alert includes a drug-drug interaction, a drug-disease interaction, or both a drug-drug interaction and a drug-disease interaction.

6. The method of claim 1, wherein the claims data of the patient includes prescription drug claims data and medical claims data.

7. The method of claim 1, wherein in response to receipt of the purchaser indication that the OTC drug product is for acute use, transmitting, on the computing device, a second request and the token to the second computing device to perform a second drug utilization review (DUR) based on the OTC drug product for acute use and the claims data of the patient and providing the DUR to the patient without saving the acute use OTC drug product in the claims data for the patient.

8. The method of claim 1, wherein the acute use is a single illness episodic use for a condition of less than 14 days and chronic use is for an illness condition or greater than 14 days.

14. The method of claim 1 wherein receiving the purchase selection comprises:

receiving, via the Internet on the computing device, an image of a label of the over-the-counter (OTC) drug product indicating the purchase selection from the user device of the OTC drug product; and

converting, by the computing device, the image into electronic data that identifies the OTC drug product.

15. The method of claim 1, further comprising:

transmitting, by the computing device, a product code associated with the OTC drug product and the token to the second computing device; and

receiving, by the computing device, a drug code associated with the product code when the token is valid after the second computing device maps the product code to the drug code for the OTC drug product.

9. A non-transitory computer-readable medium containing instructions that cause a data processing system to perform a method for coordinating a service, the method comprising:

receiving, via the Internet on a computing device, a purchase selection from a user device of an over-the-counter (OTC) drug product;

receiving, via the Internet on the computing device, associated usage data reflecting a purchaser indication from the user device of whether the OTC drug product is for chronic use or acute use;

accessing, on the computing device, a claims database storing claims data of a patient associated with the OTC drug product;

accessing, on the computing device, a second computing device;

receiving, on the computing device, a token from the second computing device, the token being valid for a predetermined period of time;

in response to receipt of the purchaser indication that the OTC drug product is for chronic use, transmitting, on the computing device, a request and the token to the second computing device to perform a drug utilization review (DUR) based on the OTC drug product and the claims data of the patient;

receiving, on the computing device, a drug interaction alert based on performance of the DUR when the token is valid;

when the drug interaction alert is for a severe interaction, generating and transmitting a notification to the user device via the Internet reflecting that purchase of the identified OTC drug product cannot be completed based on the drug interaction alert; and

when the drug interaction alert is not for a severe interaction, processing the purchase selection of the OTC drug product,

wherein the computing device prompts a user to re-login when the token is not valid.

10. The medium of claim 9, further comprising:

classifying the drug interaction alert as being for a severe interaction or for a non-severe interaction.

11. The medium of claim 9, further comprising:

altering a drug profile of the patient to reflect acute use of the OTC drug product.

12. The medium of claim 9, wherein the acute use is a single episodic use for a condition of less than 14 days.

13. The medium of claim 9, wherein in response to receipt of the purchaser indication that the OTC drug product is for acute use, transmitting, on the computing device, a second request and the token to the second computing device to perform a second drug utilization review (DUR) based on the OTC drug product for acute use and the claims data of the patient and providing the DUR to the patient without saving the acute use OTC drug product in the claims data for the patient.